Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
E

Failure to Address GDR Requests and Communicate Psych NP Recommendations for Psychotropic Medications

Bossier City, Louisiana Survey Completed on 08-07-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident receiving psychotropic medications was free from unnecessary drugs. Specifically, there was no evidence that pharmacy requests for gradual dose reductions (GDR) for medications including Risperidone, Seroquel, Cymbalta, and Temazepam were addressed by the physician over the past year. The resident in question had a history of multiple psychiatric diagnoses, including insomnia, major depressive disorder, bipolar disorder, and anxiety disorder, and was assessed as having moderate cognitive impairment. Despite ongoing orders for these medications, the required pharmacy GDR requests were not documented as being communicated to or considered by the physician. Additionally, the facility did not ensure that recommendations from a psychiatric nurse practitioner (Psych NP) to decrease the dosage of Risperidone were communicated to the physician. Progress notes from the Psych NP included recommendations to reduce the medication, but there was no evidence in the medical record that these recommendations were sent to the physician or that any physician response was received. Interviews with the DON and ADON confirmed the lack of documentation and communication regarding both the pharmacy GDR requests and the Psych NP's recommendations.

An unhandled error has occurred. Reload 🗙